EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reactivation of hidden-latent Brucella infection after doxycycline and streptomycin treatment in mice

Eugenia Sancho-Sánchez, Kimberly García-Arteaga, Fabio Granados-Chinchilla, Graciela Artavia, Alejandro Alfaro-Alarcón, Andrés Villalobos-Villalobos, Laura Bouza-Mora, Marcela Suárez-Esquivel, Carlos Chacón-Díaz iD, Caterina Guzmán-Verri, Edgardo Moreno iD, Elías Barquero-Calvo iD

Antimicrobial Agents and Chemotherapy · 13.02.2025 · 69 (2)

DOI: 10.1128/aac.01302-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 13.02.2025. Verfasst von Eugenia Sancho-Sánchez und 11 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Investigación en Enfermedades Tropicales, Escuela de Medicina Veterinaria, Universidad Nacional, Heredia, Costa Rica. Hauptthemen laut MEDLINE: Doxycycline, Streptomycin, Brucellosis, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Rectores (CONARE).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brucellosis has therapeutic challenges due to 3%–15% relapses/therapeutic failures (R/TF) after antibiotic treatment. Therefore, determining the antibiotic concentration in tissues, the physiopathological parameters, and the R/TF after treatment is relevant. After exploring different antibiotic quantities, we found that a combined dose of 100 µg/g of doxycycline (for 45 days) and 7.5 µg/g of streptomycin (for 14 days), respectively, achieved therapeutic levels of more than fourfold minimum inhibitory concentrations (MICs) against Brucella abortus in the spleen, liver, bone marrow, and plasma of mice, causing minimal pathophysiological effects. After 30 days of infection, mice received antibiotics, and hematological, histopathological, biochemical, and immunological analyses were performed. After antibiotic therapy, the pathological, hematological, immunological, and physiological profiles paralleled those described in human brucellosis. Treatment lowered antibody titers, reduced proinflammatory cytokines, and reduced inflammation in the target organs for a protracted period. No bacteria were detected in tissues 8 weeks after treatment, suggesting complete recovery. However, despite high doxycycline and streptomycin concentrations in tissues, relapses appeared in 100% of the animals after 182 days post-infection, estimated by the bacterial counts and PCR from organs. This proportion contrasts with the 15% R/TF observed in humans after antibiotic treatments. None of the B. abortus isolated from relapses showed augmented MICs or mutations coding for antibiotic resistance in chromosomal-relevant regions. We discuss whether our findings constitute a general phenomenon or differences in the exhaustive screening method for bacteria detection related to the murine model. Along these lines, we envision likely mechanisms of bacterial persistence in tissues after antibiotic treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxycyclineStreptomycinBrucellosisAnti-Bacterial AgentsBrucella abortusAnimalsMiceFemaleMicrobial Sensitivity TestsMice, Inbred BALB CLiverSpleen

Stichwörter der Autor:innen

INF-γantibiotic resistanceantibiotic treatmentbrucellosiscytokinesdoxycyclinerelapsesstreptomycin

Substanzen

DoxycyclineStreptomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Programa de Investigación en Enfermedades Tropicales, Escuela de Medicina Veterinaria, Universidad Nacional, Heredia, Costa Rica.
  • Centro de Investigación en Enfermedades Tropicales, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica.
  • Escuela de Química, Universidad de Costa Rica, Sede Rodrigo Facio, San Pedro Montes de Oca, San José, Costa Rica.
  • Centro Nacional de Ciencia y Tecnología de Alimentos, Universidad de Costa Rica, San José, Costa Rica.
  • Departamento de Patología, Escuela de Medicina Veterinaria, Universidad Nacional, Heredia, Costa Rica.
  • Berlin Institute of Health, Institute of Virology, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.

ORCID-Profile: Carlos Chacón-Díaz, Edgardo Moreno, Elías Barquero-Calvo

Förderung

  • Consejo Nacional de Rectores (CONARE)

Zitieren

APA

Sancho-Sánchez, E., García-Arteaga, K., Granados-Chinchilla, F., Artavia, G., Alfaro-Alarcón, A., Villalobos-Villalobos, A., Bouza-Mora, L., Suárez-Esquivel, M., Chacón-Díaz, C., Guzmán-Verri, C., Moreno, E., & Barquero-Calvo, E. (2025). Reactivation of hidden-latent Brucella infection after doxycycline and streptomycin treatment in mice. Antimicrobial Agents and Chemotherapy, 69(2). https://doi.org/10.1128/aac.01302-24

Vancouver

Sancho-Sánchez E, García-Arteaga K, Granados-Chinchilla F, Artavia G, Alfaro-Alarcón A, Villalobos-Villalobos A, et al. Reactivation of hidden-latent Brucella infection after doxycycline and streptomycin treatment in mice. Antimicrobial Agents and Chemotherapy. 2025;69(2). doi:10.1128/aac.01302-24

BibTeX
@article{SanchoSnchez2025,
  author = {Sancho-Sánchez, Eugenia and García-Arteaga, Kimberly and Granados-Chinchilla, Fabio and Artavia, Graciela and Alfaro-Alarcón, Alejandro and Villalobos-Villalobos, Andrés and Bouza-Mora, Laura and Suárez-Esquivel, Marcela and Chacón-Díaz, Carlos and Guzmán-Verri, Caterina and Moreno, Edgardo and Barquero-Calvo, Elías},
  title = {Reactivation of hidden-latent Brucella infection after doxycycline and streptomycin treatment in mice},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  volume = {69},
  number = {2},
  doi = {10.1128/aac.01302-24}
}
Kostenlos starten →